Department of Clinical Psychology and Psychotherapy, Philipps University Marburg
Marburg, 35032, Germany
NCT Number: NCT02787148
Prospective studies indicate that patients with depression are at increased risk for cardiovascular disease. Depression is also associated with a number of hemodynamic features, which are known risk factors for cardiovascular morbidity such as increased heart rate, reduced heart rate variability and blood pressure alterations. These hemodynamic alterations may explain in part the increased cardiovascular risk associated with depression.
The purpose of this study is to determine whether treatment for depression with cognitive behavior therapy (CBT) is effective in reducing hemodynamic cardiovascular risk factors. Hemodynamic assessments including heart rate, heart rate variability, continues blood pressure, blood pressure variability, baroreceptor sensitivity and peripheral vascular resistance will be conducted at baseline, after treatment and 2-month follow up. In addition, circadian hemodynamic variations such as 24-hour heart rate variability, nocturnal blood pressure dipping and immunological biomarkers will be assessed. Eighty patients with Major Depression will be randomly assigned to either a CBT treatment condition (14 hour-long, weekly sessions) or a waitlist condition, to control for potential changes in hemodynamic parameters without any intervention and the impact of repeated-measurement.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Marburg, 35032, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Change from baseline (beginning of therapy) to 3 month after baseline, to 2-month-follow up
Time frame: Change from baseline (beginning of therapy) to 3 month after baseline, to 2-month-follow up
Time frame: Change from baseline (beginning of therapy) to 3 month after baseline, to 2-month-follow up
Time frame: Change from baseline (beginning of therapy) to 3 month after baseline, to 2-month-follow up
Time frame: Change from baseline (beginning of therapy) to 3 month after baseline, to 2-month-follow up
Time frame: Change from baseline (beginning of therapy) to 3 month after baseline, to 2-month-follow up
Time frame: Change from baseline (beginning of therapy) to 3 month after baseline, to 2-month-follow up
Time frame: Change from baseline (beginning of therapy) to 3 month after baseline, to 2-month-follow up
Time frame: Change from baseline (beginning of therapy) to 3 month after baseline, to 2-month-follow up
Philipps University Marburg
Other
The Impact of Psychotherapy on Hemodynamic and Inflammatory Risk Factors for Cardiovascular Disease in Major Depression
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06139016
Behavior, Behavioral Symptoms
New Haven, Connecticut, United States
View Trial DetailsNCT06942637
Adolescents, Anxiety
Bandung, West Java, Indonesia
View Trial DetailsNCT04276259
Behavior, Behavioral Symptoms
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT07737652
Anxiety, Anxiety Disorders
Tuscaloosa, Alabama, United States
View Trial Details